{"id":368166,"date":"2025-11-29T14:00:39","date_gmt":"2025-11-29T08:30:39","guid":{"rendered":"https:\/\/www.scconline.com\/blog\/?p=368166"},"modified":"2025-11-29T13:36:24","modified_gmt":"2025-11-29T08:06:24","slug":"cyril-amarchand-mangaldas-acted-as-the-indian-legal-counsel-to-sudeep-pharma-limited-on-the-initial-public-offering-of-its-equity-shares","status":"publish","type":"post","link":"https:\/\/www.scconline.com\/blog\/post\/2025\/11\/29\/cyril-amarchand-mangaldas-acted-as-the-indian-legal-counsel-to-sudeep-pharma-limited-on-the-initial-public-offering-of-its-equity-shares\/","title":{"rendered":"Cyril Amarchand Mangaldas acted as the Indian legal counsel to Sudeep Pharma Limited on the initial public offering of its equity shares."},"content":{"rendered":"
\n

Cyril Amarchand Mangaldas (“CAM<\/span>‘) acted as the Indian legal counsel to Sudeep Pharma Limited (“Company<\/span>”) on the initial public offering of its equity shares (“Offer<\/span>”). The Offer comprised a fresh issue, and an offer for sale of by the promoter selling shareholders.<\/p>\n

The book running lead managers to the Offer were ICICI Securities Limited and IIFL Capital Services Limited (formerly known as IIFL Securities Limited).<\/p>\n

The Offer opened on Friday, November 21, 2025 and closed on Tuesday, November 25, 2025, and received an overall subscription of 93.71 times, with the portion reserved for qualified institutional buyers being subscribed 213.08 times, as per the data available on the National Stock Exchange of India’s website. The equity shares of the Company commenced trading on the stock exchanges on Friday, November 28, 2025.<\/p>\n

The Company is a technology led manufacturer of excipients and specialty ingredients for the pharmaceutical, food and nutrition industries.<\/p>\n

The transaction was led by Ravi Dubey<\/span>, Partner (Regional Co-Head – Capital Markets – West); with support from Radhika Pandey<\/span>, Principal Associate; Esha Gupta<\/span>, Associate; Anomitra Debnath<\/span>, Associate; Harshita Pareek<\/span>, Associate; and Khushi Parekh<\/span>, Associate.<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

Comprising a fresh issue and offer for sale by promoter shareholders. The IPO saw an exceptional overall subscription of 93.71 times, with QIB demand at 213.08 times.<\/p>\n","protected":false},"author":67011,"featured_media":368170,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_jetpack_memberships_contains_paid_content":false,"footnotes":""},"categories":[45282,2],"tags":[93581,30960,74146,93644,85405,93647,93646,93645,93642,93643],"class_list":["post-368166","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-law-firms-news","category-news","tag-cam-capital-markets","tag-cyril-amarchand-mangaldas","tag-icici-securities","tag-iifl-capital-services","tag-india-ipo-2025","tag-indian-equity-markets","tag-nse-ipo-subscription","tag-pharmaceutical-excipients-ipo","tag-sudeep-pharma-ipo","tag-sudeep-pharma-limited"],"yoast_head":"\nCyril Amarchand Mangaldas acted as the Indian legal counsel to Sudeep Pharma Limited on the initial public offering of its equity shares | SCC Times<\/title>\n<meta name=\"description\" content=\"Cyril Amarchand Mangaldas advised Sudeep Pharma Limited on its IPO, which achieved 93.71\u00d7 overall subscription and 213.08\u00d7 QIB participation.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.scconline.com\/blog\/post\/2025\/11\/29\/cyril-amarchand-mangaldas-acted-as-the-indian-legal-counsel-to-sudeep-pharma-limited-on-the-initial-public-offering-of-its-equity-shares\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Cyril Amarchand Mangaldas acted as the Indian legal counsel to Sudeep Pharma Limited on the initial public offering of its equity shares.\" \/>\n<meta property=\"og:description\" content=\"Cyril Amarchand Mangaldas advised Sudeep Pharma Limited on its IPO, which achieved 93.71\u00d7 overall subscription and 213.08\u00d7 QIB participation.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.scconline.com\/blog\/post\/2025\/11\/29\/cyril-amarchand-mangaldas-acted-as-the-indian-legal-counsel-to-sudeep-pharma-limited-on-the-initial-public-offering-of-its-equity-shares\/\" \/>\n<meta property=\"og:site_name\" content=\"SCC Times\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/scc.online\/\" \/>\n<meta property=\"article:published_time\" content=\"2025-11-29T08:30:39+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.scconline.com\/blog\/wp-content\/uploads\/2025\/11\/CAM-Sudeep-Pharma-IPO.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"886\" \/>\n\t<meta property=\"og:image:height\" content=\"590\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Editor\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:title\" content=\"Cyril Amarchand Mangaldas acted as the Indian legal counsel to Sudeep Pharma Limited on the initial public offering of its equity shares.\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Editor\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.scconline.com\/blog\/post\/2025\/11\/29\/cyril-amarchand-mangaldas-acted-as-the-indian-legal-counsel-to-sudeep-pharma-limited-on-the-initial-public-offering-of-its-equity-shares\/\",\"url\":\"https:\/\/www.scconline.com\/blog\/post\/2025\/11\/29\/cyril-amarchand-mangaldas-acted-as-the-indian-legal-counsel-to-sudeep-pharma-limited-on-the-initial-public-offering-of-its-equity-shares\/\",\"name\":\"Cyril Amarchand Mangaldas acted as the Indian legal counsel to Sudeep Pharma Limited on the initial public offering of its equity shares | SCC Times\",\"isPartOf\":{\"@id\":\"https:\/\/www.scconline.com\/blog\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.scconline.com\/blog\/post\/2025\/11\/29\/cyril-amarchand-mangaldas-acted-as-the-indian-legal-counsel-to-sudeep-pharma-limited-on-the-initial-public-offering-of-its-equity-shares\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.scconline.com\/blog\/post\/2025\/11\/29\/cyril-amarchand-mangaldas-acted-as-the-indian-legal-counsel-to-sudeep-pharma-limited-on-the-initial-public-offering-of-its-equity-shares\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.scconline.com\/blog\/wp-content\/uploads\/2025\/11\/CAM-Sudeep-Pharma-IPO.webp\",\"datePublished\":\"2025-11-29T08:30:39+00:00\",\"author\":{\"@id\":\"https:\/\/www.scconline.com\/blog\/#\/schema\/person\/84e42bab48238baf12c7e33b3d9761fe\"},\"description\":\"Cyril Amarchand Mangaldas advised Sudeep Pharma Limited on its IPO, which achieved 93.71\u00d7 overall subscription and 213.08\u00d7 QIB participation.\",\"breadcrumb\":{\"@id\":\"https:\/\/www.scconline.com\/blog\/post\/2025\/11\/29\/cyril-amarchand-mangaldas-acted-as-the-indian-legal-counsel-to-sudeep-pharma-limited-on-the-initial-public-offering-of-its-equity-shares\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.scconline.com\/blog\/post\/2025\/11\/29\/cyril-amarchand-mangaldas-acted-as-the-indian-legal-counsel-to-sudeep-pharma-limited-on-the-initial-public-offering-of-its-equity-shares\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.scconline.com\/blog\/post\/2025\/11\/29\/cyril-amarchand-mangaldas-acted-as-the-indian-legal-counsel-to-sudeep-pharma-limited-on-the-initial-public-offering-of-its-equity-shares\/#primaryimage\",\"url\":\"https:\/\/www.scconline.com\/blog\/wp-content\/uploads\/2025\/11\/CAM-Sudeep-Pharma-IPO.webp\",\"contentUrl\":\"https:\/\/www.scconline.com\/blog\/wp-content\/uploads\/2025\/11\/CAM-Sudeep-Pharma-IPO.webp\",\"width\":886,\"height\":590,\"caption\":\"CAM Sudeep Pharma IPO\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.scconline.com\/blog\/post\/2025\/11\/29\/cyril-amarchand-mangaldas-acted-as-the-indian-legal-counsel-to-sudeep-pharma-limited-on-the-initial-public-offering-of-its-equity-shares\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.scconline.com\/blog\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Cyril Amarchand Mangaldas acted as the Indian legal counsel to Sudeep Pharma Limited on the initial public offering of its equity shares.\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.scconline.com\/blog\/#website\",\"url\":\"https:\/\/www.scconline.com\/blog\/\",\"name\":\"SCC Times\",\"description\":\"Bringing you the Best Analytical Legal News\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.scconline.com\/blog\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.scconline.com\/blog\/#\/schema\/person\/84e42bab48238baf12c7e33b3d9761fe\",\"name\":\"Editor\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.scconline.com\/blog\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/34e366be721c41333586de05faa13743195f5b142dcd7a015c6fabd2389521d0?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/34e366be721c41333586de05faa13743195f5b142dcd7a015c6fabd2389521d0?s=96&d=mm&r=g\",\"caption\":\"Editor\"},\"url\":\"https:\/\/www.scconline.com\/blog\/post\/author\/editor_4\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Cyril Amarchand Mangaldas acted as the Indian legal counsel to Sudeep Pharma Limited on the initial public offering of its equity shares | SCC Times","description":"Cyril Amarchand Mangaldas advised Sudeep Pharma Limited on its IPO, which achieved 93.71\u00d7 overall subscription and 213.08\u00d7 QIB participation.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.scconline.com\/blog\/post\/2025\/11\/29\/cyril-amarchand-mangaldas-acted-as-the-indian-legal-counsel-to-sudeep-pharma-limited-on-the-initial-public-offering-of-its-equity-shares\/","og_locale":"en_US","og_type":"article","og_title":"Cyril Amarchand Mangaldas acted as the Indian legal counsel to Sudeep Pharma Limited on the initial public offering of its equity shares.","og_description":"Cyril Amarchand Mangaldas advised Sudeep Pharma Limited on its IPO, which achieved 93.71\u00d7 overall subscription and 213.08\u00d7 QIB participation.","og_url":"https:\/\/www.scconline.com\/blog\/post\/2025\/11\/29\/cyril-amarchand-mangaldas-acted-as-the-indian-legal-counsel-to-sudeep-pharma-limited-on-the-initial-public-offering-of-its-equity-shares\/","og_site_name":"SCC Times","article_publisher":"https:\/\/www.facebook.com\/scc.online\/","article_published_time":"2025-11-29T08:30:39+00:00","og_image":[{"width":886,"height":590,"url":"https:\/\/www.scconline.com\/blog\/wp-content\/uploads\/2025\/11\/CAM-Sudeep-Pharma-IPO.jpg","type":"image\/jpeg"}],"author":"Editor","twitter_card":"summary_large_image","twitter_title":"Cyril Amarchand Mangaldas acted as the Indian legal counsel to Sudeep Pharma Limited on the initial public offering of its equity shares.","twitter_misc":{"Written by":"Editor","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.scconline.com\/blog\/post\/2025\/11\/29\/cyril-amarchand-mangaldas-acted-as-the-indian-legal-counsel-to-sudeep-pharma-limited-on-the-initial-public-offering-of-its-equity-shares\/","url":"https:\/\/www.scconline.com\/blog\/post\/2025\/11\/29\/cyril-amarchand-mangaldas-acted-as-the-indian-legal-counsel-to-sudeep-pharma-limited-on-the-initial-public-offering-of-its-equity-shares\/","name":"Cyril Amarchand Mangaldas acted as the Indian legal counsel to Sudeep Pharma Limited on the initial public offering of its equity shares | SCC Times","isPartOf":{"@id":"https:\/\/www.scconline.com\/blog\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.scconline.com\/blog\/post\/2025\/11\/29\/cyril-amarchand-mangaldas-acted-as-the-indian-legal-counsel-to-sudeep-pharma-limited-on-the-initial-public-offering-of-its-equity-shares\/#primaryimage"},"image":{"@id":"https:\/\/www.scconline.com\/blog\/post\/2025\/11\/29\/cyril-amarchand-mangaldas-acted-as-the-indian-legal-counsel-to-sudeep-pharma-limited-on-the-initial-public-offering-of-its-equity-shares\/#primaryimage"},"thumbnailUrl":"https:\/\/www.scconline.com\/blog\/wp-content\/uploads\/2025\/11\/CAM-Sudeep-Pharma-IPO.webp","datePublished":"2025-11-29T08:30:39+00:00","author":{"@id":"https:\/\/www.scconline.com\/blog\/#\/schema\/person\/84e42bab48238baf12c7e33b3d9761fe"},"description":"Cyril Amarchand Mangaldas advised Sudeep Pharma Limited on its IPO, which achieved 93.71\u00d7 overall subscription and 213.08\u00d7 QIB participation.","breadcrumb":{"@id":"https:\/\/www.scconline.com\/blog\/post\/2025\/11\/29\/cyril-amarchand-mangaldas-acted-as-the-indian-legal-counsel-to-sudeep-pharma-limited-on-the-initial-public-offering-of-its-equity-shares\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.scconline.com\/blog\/post\/2025\/11\/29\/cyril-amarchand-mangaldas-acted-as-the-indian-legal-counsel-to-sudeep-pharma-limited-on-the-initial-public-offering-of-its-equity-shares\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.scconline.com\/blog\/post\/2025\/11\/29\/cyril-amarchand-mangaldas-acted-as-the-indian-legal-counsel-to-sudeep-pharma-limited-on-the-initial-public-offering-of-its-equity-shares\/#primaryimage","url":"https:\/\/www.scconline.com\/blog\/wp-content\/uploads\/2025\/11\/CAM-Sudeep-Pharma-IPO.webp","contentUrl":"https:\/\/www.scconline.com\/blog\/wp-content\/uploads\/2025\/11\/CAM-Sudeep-Pharma-IPO.webp","width":886,"height":590,"caption":"CAM Sudeep Pharma IPO"},{"@type":"BreadcrumbList","@id":"https:\/\/www.scconline.com\/blog\/post\/2025\/11\/29\/cyril-amarchand-mangaldas-acted-as-the-indian-legal-counsel-to-sudeep-pharma-limited-on-the-initial-public-offering-of-its-equity-shares\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.scconline.com\/blog\/"},{"@type":"ListItem","position":2,"name":"Cyril Amarchand Mangaldas acted as the Indian legal counsel to Sudeep Pharma Limited on the initial public offering of its equity shares."}]},{"@type":"WebSite","@id":"https:\/\/www.scconline.com\/blog\/#website","url":"https:\/\/www.scconline.com\/blog\/","name":"SCC Times","description":"Bringing you the Best Analytical Legal News","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.scconline.com\/blog\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.scconline.com\/blog\/#\/schema\/person\/84e42bab48238baf12c7e33b3d9761fe","name":"Editor","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.scconline.com\/blog\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/34e366be721c41333586de05faa13743195f5b142dcd7a015c6fabd2389521d0?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/34e366be721c41333586de05faa13743195f5b142dcd7a015c6fabd2389521d0?s=96&d=mm&r=g","caption":"Editor"},"url":"https:\/\/www.scconline.com\/blog\/post\/author\/editor_4\/"}]}},"jetpack_featured_media_url":"https:\/\/www.scconline.com\/blog\/wp-content\/uploads\/2025\/11\/CAM-Sudeep-Pharma-IPO.webp","jetpack_sharing_enabled":true,"jetpack-related-posts":[{"id":380692,"url":"https:\/\/www.scconline.com\/blog\/post\/2026\/04\/10\/cam-advises-powerica-ipo-1100-crore-listing\/","url_meta":{"origin":368166,"position":0},"title":"Cyril Amarchand Mangaldas acted as the Indian legal counsel to Powerica Limited on its IPO of INR 11,000 million","author":"Editor","date":"April 10, 2026","format":false,"excerpt":"","rel":"","context":"In "Law Firms News"","block_context":{"text":"Law Firms News","link":"https:\/\/www.scconline.com\/blog\/post\/category\/news\/law-firms-news\/"},"img":{"alt_text":"CAM Advises Powerica IPO","src":"https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2026\/04\/CAM-Advises-Powerica-IPO.webp?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2026\/04\/CAM-Advises-Powerica-IPO.webp?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2026\/04\/CAM-Advises-Powerica-IPO.webp?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2026\/04\/CAM-Advises-Powerica-IPO.webp?resize=700%2C400&ssl=1 2x"},"classes":[]},{"id":363989,"url":"https:\/\/www.scconline.com\/blog\/post\/2025\/10\/16\/cyril-amarchand-mangaldas-tata-capital-ipo\/","url_meta":{"origin":368166,"position":1},"title":"Cyril Amarchand Mangaldas advises Tata Sons and Tata Capital on Rs. 15,511.87 Crore IPO of Tata Capital Ltd.","author":"Editor","date":"October 16, 2025","format":false,"excerpt":"This is the largest IPO ever by the Tata Group, the biggest by an NBFC in India, and the largest IPO of 2025. It also ranks as the fourth largest IPO in Indian market history, marking a major milestone for the company and the financial sector.","rel":"","context":"In "Law Firms News"","block_context":{"text":"Law Firms News","link":"https:\/\/www.scconline.com\/blog\/post\/category\/news\/law-firms-news\/"},"img":{"alt_text":"Tata Capital IPO","src":"https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2025\/10\/Tata-Capital-IPO.webp?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2025\/10\/Tata-Capital-IPO.webp?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2025\/10\/Tata-Capital-IPO.webp?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2025\/10\/Tata-Capital-IPO.webp?resize=700%2C400&ssl=1 2x"},"classes":[]},{"id":354597,"url":"https:\/\/www.scconline.com\/blog\/post\/2025\/07\/25\/cyril-amarchand-advises-hdb-financial-ipo\/","url_meta":{"origin":368166,"position":2},"title":"Cyril Amarchand Mangaldas advises HDB Financial Services on its Initial Public Offering","author":"Editor","date":"July 25, 2025","format":false,"excerpt":"CAM advised HDB Financial Services Limited (\u201cCompany\u201d), as the Indian legal counsel to the Company in its initial public offering of 168,918,917 equity shares aggregating to \u20b9 125,000.0 million (\u201cOffer\u201d). The Offer consisted of a fresh issue of 33,783,782 equity shares aggregating to \u20b9 25,000.0 million and an offer for\u2026","rel":"","context":"In "Law Firms News"","block_context":{"text":"Law Firms News","link":"https:\/\/www.scconline.com\/blog\/post\/category\/news\/law-firms-news\/"},"img":{"alt_text":"CAM Advises HDB Financial Services on IPO","src":"https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2025\/07\/CAM-Advises-HDB-Financial-Services-on-IPO.webp?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2025\/07\/CAM-Advises-HDB-Financial-Services-on-IPO.webp?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2025\/07\/CAM-Advises-HDB-Financial-Services-on-IPO.webp?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2025\/07\/CAM-Advises-HDB-Financial-Services-on-IPO.webp?resize=700%2C400&ssl=1 2x"},"classes":[]},{"id":362523,"url":"https:\/\/www.scconline.com\/blog\/post\/2025\/10\/04\/cam-advises-ivalue-infosolutions-ipo\/","url_meta":{"origin":368166,"position":3},"title":"Cyril Amarchand Mangaldas advises Ivalue Infosolutions Limited on its IPO","author":"Editor","date":"October 4, 2025","format":false,"excerpt":"The book running lead managers of this deal were IIFL Capital Services Limited (formerly known as IIFL Securities Limited) and Motilal Oswal Investment Advisors Limited.","rel":"","context":"In "Law Firms News"","block_context":{"text":"Law Firms News","link":"https:\/\/www.scconline.com\/blog\/post\/category\/news\/law-firms-news\/"},"img":{"alt_text":"Ivalue Infosolutions Limited","src":"https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2025\/10\/Ivalue-Infosolutions-Limited.webp?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2025\/10\/Ivalue-Infosolutions-Limited.webp?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2025\/10\/Ivalue-Infosolutions-Limited.webp?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2025\/10\/Ivalue-Infosolutions-Limited.webp?resize=700%2C400&ssl=1 2x"},"classes":[]},{"id":331010,"url":"https:\/\/www.scconline.com\/blog\/post\/2024\/09\/18\/cyril-amarchand-mangaldas-acts-as-legal-counsel-for-bajaj-housing-finance-limited-and-bajaj-finance-limited-on-the-ipo-of-equity-shares-of-the-company\/","url_meta":{"origin":368166,"position":4},"title":"Cyril Amarchand Mangaldas acts as legal counsel for Bajaj Housing Finance Limited and Bajaj Finance Limited on the IPO of equity shares of the Company","author":"Bhumika Indulia","date":"September 18, 2024","format":false,"excerpt":"Cyril Amarchand Mangaldas (CAM) acted as the Indian legal counsel to Bajaj Housing Finance Limited (the \u201cCompany\u201d) and Bajaj Finance Limited","rel":"","context":"In "Law Firms News"","block_context":{"text":"Law Firms News","link":"https:\/\/www.scconline.com\/blog\/post\/category\/news\/law-firms-news\/"},"img":{"alt_text":"Bajaj Housing Finance Limited","src":"https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2024\/09\/cyril-49.webp?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2024\/09\/cyril-49.webp?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2024\/09\/cyril-49.webp?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2024\/09\/cyril-49.webp?resize=700%2C400&ssl=1 2x"},"classes":[]},{"id":370596,"url":"https:\/\/www.scconline.com\/blog\/post\/2025\/12\/23\/shardul-amarchand-mangaldas-advises-icici-prudential-amc-ipo-2025\/","url_meta":{"origin":368166,"position":5},"title":"Shardul Amarchand Mangaldas & Co. advises the Book Running Lead Managers on the \u20b910,602 crore initial public offering of ICICI Prudential Asset Management Company Limited","author":"Editor","date":"December 23, 2025","format":false,"excerpt":"Shardul Amarchand Mangaldas advised the Book Running Lead Managers on ICICI Prudential AMC\u2019s \u20b910,602 crore IPO, one of India\u2019s largest offerings, listed on BSE and NSE in December 2025.","rel":"","context":"In "Law Firms News"","block_context":{"text":"Law Firms News","link":"https:\/\/www.scconline.com\/blog\/post\/category\/news\/law-firms-news\/"},"img":{"alt_text":"ICICI Prudential AMC IPO legal advisors","src":"https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2025\/12\/ICICI-Prudential-AMC-IPO-legal-advisors.webp?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2025\/12\/ICICI-Prudential-AMC-IPO-legal-advisors.webp?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2025\/12\/ICICI-Prudential-AMC-IPO-legal-advisors.webp?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2025\/12\/ICICI-Prudential-AMC-IPO-legal-advisors.webp?resize=700%2C400&ssl=1 2x"},"classes":[]}],"amp_enabled":true,"_links":{"self":[{"href":"https:\/\/www.scconline.com\/blog\/wp-json\/wp\/v2\/posts\/368166","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.scconline.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.scconline.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.scconline.com\/blog\/wp-json\/wp\/v2\/users\/67011"}],"replies":[{"embeddable":true,"href":"https:\/\/www.scconline.com\/blog\/wp-json\/wp\/v2\/comments?post=368166"}],"version-history":[{"count":0,"href":"https:\/\/www.scconline.com\/blog\/wp-json\/wp\/v2\/posts\/368166\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.scconline.com\/blog\/wp-json\/wp\/v2\/media\/368170"}],"wp:attachment":[{"href":"https:\/\/www.scconline.com\/blog\/wp-json\/wp\/v2\/media?parent=368166"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.scconline.com\/blog\/wp-json\/wp\/v2\/categories?post=368166"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.scconline.com\/blog\/wp-json\/wp\/v2\/tags?post=368166"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}